Prevalence of comorbidities in chronic obstructive pulmonary disease patients

Medicine (United States)

Volumn 96, Issue 19, 2017, Pages

  Yin, Hong Lei ^a   Yin, Shi Qi ^b   Lin, Qing Yan ^a   Xu, Ying ^a   Xu, Hong Wei ^a   Liu, Tao ^a  

^a HEILONGJIANG PROVINCIAL HOSPITAL   (China)

^b Heilongjiang Electric Power Co Ltd   (China)

Author keywords

chronic obstructive pulmonary disease; comorbidities; COPD; prevalence

Indexed keywords

ANEMIA; ATHEROSCLEROSIS; ATOPIC DERMATITIS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; COMPARATIVE STUDY; DATA BASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENTEROPATHY; GASTROINTESTINAL DISEASE; HEAD INJURY; HEART DISEASE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; MALIGNANT NEOPLASM; MENTAL DISEASE; META ANALYSIS; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OBESITY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SENSITIVITY ANALYSIS; SINUSITIS; SKIN DISEASE; SYSTEMATIC REVIEW; THROMBOSIS; THYROID DISEASE; COMPLICATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

COMORBIDITY; HUMANS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 85019431298     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000006836     Document Type: Review

References (37)

1. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007;370:741-50.
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380:2095-128.
3. Mannino DM, Brown C, Giovino GA. Obstructive lung disease in the United States from 1979 to 1993: an analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997;156:814-8.
4. Petty TL. Definitions, causes, course, and prognosis of chronic obstructive pulmonary disease. Respir Care Clin N Am 1998;4:345-58.
5. Brown JP, Martinez CH. Chronic obstructive pulmonary disease comorbidities. Curr Opin Pulm Med 2016;22:113-8.
6. Lundback B, Lindberg A, Lindstrom M, et al. Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003;97:115-22.
7. Stoller JKAL. Alpha 1-antitrypsin deficiency. Lancet 2005;365:2225-36.
8. Tai A, Tran H, Roberts M, et al. The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 2014;69:805-10.
9. Garcia-Sanz MT, Canive-Gomez JC, Garcia-Couceiro N, et al. Factors associated with the incidence of serious adverse events in patients admitted with COPD acute exacerbation. Ir J Med Sci 2016;[Epub ahead of print].
10. Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008;121:789-96.
11. Hillas G, Perlikos F, Tsiligianni I, et al. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis 2015;10:95-109.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
13. National Heart, Lung, and Blood Institute. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. Available at: http://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascularrisk-reduction/tools/cohort. Accessed June 2, 2016.
14. Chen SJ, Liao WC, Huang KH, et al. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. QJM 2015;108:633-40.
15. Craig BM, Kraus CK, Chewning BA, et al. Quality of care for older adults with chronic obstructive pulmonary disease and asthma based on comparisons to practice guidelines and smoking status.BMCHealth Serv Res 2008;8:144-9.
16. Holguin F, Folch E, Redd SC, et al. Comorbidity and mortality in COPDrelated hospitalizations in the United States, 1979 to 2001. Chest 2005;128:2005-11.
17. Hung WW, Wisnivesky JP, Siu AL, et al. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009;180:134-7.
18. Jo YS, Choi SM, Lee J, et al. The relationship between chronic obstructive pulmonary disease and comorbidities: a cross-sectional study using data from KNHANES 2010-2012. Respir Med 2015;109:96-104.
19. Lahousse L, Niemeijer MN, van den Berg ME, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J 2015;36:1754-61.
20. Liao KM, Ho CH, Ko SC, et al. Increased risk of dementia in patients with chronic obstructive pulmonary disease. Medicine (Baltimore) 2015;94:e930.
21. Liao WC, Lin CL, Chang SN, et al. The association between chronic obstructive pulmonary disease and dementia: a population-based retrospective cohort study. Eur J Neurol 2015;22:334-40.
22. López Varela MV, Montes de Oca M, Halbert R, et al. Comorbidities and health status in individuals with and without COPD in five Latin American cities: the PLATINO study. Arch Bronconeumol 2013;49: 468-74.
23. Soderholm M, Inghammar M, Hedblad B, et al. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease. Eur J Epidemiol 2016;31:159-68.
24. van Manen JG, Bindels PJ, IJzermans CJ, et al. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001;54:287-93.
25. Connolly MJ, Lowe D, Anstey K, et al. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax 2006;61: 843-8.
26. Tsai CL, Lee WY, Hanania NA, et al. Age-related differences in clinical outcomes for acute asthma in the United States, 2006-2008. J Allergy Clin Immunol 2012;129:1252-8.
27. Wijnhoven HA, Kriegsman DM, Hesselink AE, et al. The influence of comorbidity on health-related quality of life in asthma and COPD patients. Respir Med 2003;97:468-75.
28. Hong JS, Kang HC, Kim J. Continuity of care for elderly patients with diabetes mellitus, hypertension, asthma, and chronic obstructive pulmonary disease in Korea. J Korean Med Sci 2010;25:1259-71.
29. Corrado A, Renda T, Polese G, et al. Assessment of asthma control: the SERENA study. Respir Med 2013;107:1659-66.
30. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med 2012;12:26.
31. Wardzynska A, Kubsik B, Kowalski ML. Comorbidities in elderly patients with asthma: association with control of the disease and concomitant treatment. Geriatr Gerontol Int 2015;15:902-9.
32. Soriano JB, Visick GT, Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005;128:2099-107.
33. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072-9.
34. Sundh J, Ställberg B, Lisspers K, et al. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD 2011;8:173-81.
35. Sin DD, Man SF. Skeletal muscle weakness, reduced exercise tolerance and COPD: is systemic inflammation the missing link? Thorax 2006; 61:1-3.
36. Mannino DM, Higuchi K, Yu TC, et al. Economic burden of COPD in the presence of comorbidities. Chest 2015;148:138-50.
37. Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186:155-61.